ArticleThe Journal of clinical investigation2021

The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model.

Alessandro Matte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.